“um And the third was a diagnostic prognostic test for lupus, ah which can could predict flare ups of lupus, which is extremely valuable when you can start treatment earlier. So these were super high value tests. I made a deal with a company called s sequinome that had a platform um They had the hardware on which our tests ran. And I had a strategic a global strategic deal I made with them um in order they would you know provide the system, we provide the the chemistry. And um so that was chugging along and then I was raising, and we raised a seed round, big seed round, about six million or so.”